Regulatory protein:
OGT S2013-p
PLK1 S152-p , S154-p
TBK1 T959-p
Treatment:
anti-CD3 S1697-p , S1782-p , S1783-p
BI_4834 S154-p
dasatinib S1769-p , S2129-p
EGF S1697-p , S1950-p , S1952-p , S1954-p , S2009-p , S2013-p , S2129-p
ischemia S94-p , T959-p , S966-p , S1026-p , S1076-p , T1746-p
metastatic potential S2013-p
MG132 K16-ub
MG132_withdrawal S1026-p , S1051-p
MS275 K16-ac , K2055-ac
nocodazole S142-p , S152-p , S154-p , S1556-p , S1769-p , S1922-p , T1924-p , S1926-p , S1929-p , S1957-p , T1959-p , S1961-p , S1964-p , T1966-p , S1968-p , S1971-p , T1973-p , S1975-p , S1978-p , T1980-p , S1982-p , S1985-p , T1987-p , S1989-p , S1992-p , S2009-p , S2011-p , S2013-p , S2020-p , T2022-p , S2029-p , S2031-p , T2163-p , S2181-p
SB202190 S1950-p , S1952-p , S1954-p
selumetinib S94-p
U0126 S1950-p , S1952-p
vorinostat K16-ac
ZK-Thiazolidinone S94-p , S154-p , S160-p , T2022-p